市场调查报告书

止血、组织密封胶的全球市场 2014-2020年 - 局部止血用产品 (机械性止血材料、活性和流体止血剂)、连接、组织密闭用产品 (天然组织密封胶、合成天然组织密封胶、防沾黏贴片)

Hemostasis and Tissue Sealing Agents Market (Topical Hemostats and Tissue Sealing Agents) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

出版商 Transparency Market Research 商品编码 326020
出版日期 内容资讯 英文 85 Pages
商品交期: 最快1-2个工作天内
价格
Back to Top
止血、组织密封胶的全球市场 2014-2020年 - 局部止血用产品 (机械性止血材料、活性和流体止血剂)、连接、组织密闭用产品 (天然组织密封胶、合成天然组织密封胶、防沾黏贴片) Hemostasis and Tissue Sealing Agents Market (Topical Hemostats and Tissue Sealing Agents) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
出版日期: 2015年01月27日内容资讯: 英文 85 Pages
简介

止血、组织密封胶市场,是从出血控制方面支援外科手术的止血、组织密闭、防沾黏贴片的需要广泛研究的领域。在手术中损伤血管的血流管理中这些商品担负不可缺少的角色,近几年的先进技术开发对其进步与成本效果有所贡献。

本报告以止血、组织密封胶的全球市场为焦点,提供考察现状与今后潜力所需的,全球整体及各地区的交易规模的变化检验与预测、市场推动与阻碍因素、发展机会、产业价值链、竞争环境、市场向心力等的相关分析资讯、主要加入企业简介汇整。

第1章 序

第2章 摘要整理

  • 市场简述:止血、组织密封胶的全球市场
  • 止血、组织密封胶的全球市场 - 各形式 (单位:100万美元)
    • 比较分析:组织密封胶的全球市场 - 各地区 (金额成长率)

第3章 市场概要

  • 概要
  • 市场动态
    • 市场推动要素
      • 新产品开发伴随的技术提高
      • 高涨的微创手术意愿
      • 人口高龄化增加而需要止血产品的手术
        • 全球年龄结构变化
    • 阻碍市场要素
      • 高额的成本与严厉的法规必要条件
      • 并发症风险
    • 机会
      • 新兴国家投资提供企业高收益化的良好基础
      • 坚实的研究开发
  • 波特的五力分析:止血、组织密封胶的全球市场
  • 市场向心力分析:止血、组织密封胶的全球市场 - 各地区
  • 止血、组织密封胶主要企业的全球市场占有率竞争环境 (金额构成比)
    • 止血、组织密封胶的全球市场占有率分析 - 各主要企业 (金额构成比)

第4章 止血、组织密封胶的全球市场 - 各产品形式

  • 概要
    • 全球市场收入 - 各产品形式 (单位:100万美元)
  • 局部止血用产品
    • 全球市场收入 - 各形式 (单位:100万美元)
    • 机器的止血材料
    • 活性止血剂
    • 流体止血剂
  • 连接、组织密闭用产品
    • 全球市场收入 - 各形式 (单位:100万美元)
    • 天然组织密封胶
    • 合成天然组织密封胶
    • 防止粘连产品

第5章 止血、组织密封胶的全球市场 - 各地区

  • 概要
    • 全球市场收入 - 各地区 (单位:100万美元)
  • 北美
  • 欧洲
  • 亚太地区
  • 其他地区

第6章 建议

  • 引进多用途且马上可使用的产品
  • 著重行销宣传活动
  • 对研究开发的积极配合措施

第7章 企业简介 (企业概要、财务概况、产品系列、产业策略、最新发展)

  • Advanced Medical Solutions Group plc
  • Baxter
  • Cohera Medical, Inc.
  • CryoLife, Inc.
  • C.R. Bard, Inc.
  • Johnson & Johnson Services, Inc.
  • Integra LifeSciences Corporation
  • Pfizer, Inc.
目录

The hemostasis and tissue sealing agents market involves the study of wide range of hemostat, tissue sealant and adhesion barrier products which helps the surgeons to control bleeding during the surgery. These products play an important role in management of bleeding within the damaged blood vessels in surgical procedures. The market of hemostasis and tissue sealing agents is witnessing positive growth due to the introduction of technology advanced and cost effective hemostat and tissue sealing products by key companies. For example, in June 2013, Advance Medical Solution Group plc received approval for 2-octyl cyanoacrylate synthetic tissue adhesive.

The company also offers wide range of hemostasis and tissue sealant products such as RESORBA, ActivHeal and LiquiBand. Thus, wide range of product offering will boost the uptake of these products hence drive the market growth. Other factors such as aging population and rising number surgical procedures further drive the growth of the hemostasis and tissue sealing agents market globally. For example, according to the World Health Organization (WHO), the number of people aged 65 years and above is expected to increase from 605 million to 2 billion by 2050. Aging population will boost the number of people undergoing surgical intervention which would in turn stimulate the demand of hemostat and tissue sealing agents. In addition, hemostat and tissue sealant products are still at a nascent stage in developing regions such as India and Latin America and expected to witness high growth rate in near future owing to the approval of new hemostat products by regulatory authorities. All these factors collectively fuel the revenues of hemostasis and tissue sealing agents market during the study period, hence boost market growth. However, strict regulatory policies coupled with high cost of the products will restrain the market growth worldwide.

This report encompasses a detailed study of various hemostat and tissue sealing agents. Hemostasis and tissue sealing agents market have been majorly segmented into types of products. This segment is categorized into two major type namely topical hemostats and adhesive and tissue sealant products. Topical hemostat products are further categorized into mechanical hemostat, active hemostat (i.e. thrombin based topical hemostat) and flowable hemostat (i.e. combinational topical hemostat). Hemostat products such as collagen, oxidized regenerated cellulose (ORC), gelatin and polysaccharide based topical hemostat are included under mechanical hemostat.

Adhesive and tissue sealant are classified into natural tissue sealant, synthetic tissue sealant and adhesion barrier products. Natural tissue sealant comprises fibrin sealant and others (albumin and collagen based tissue sealant). Synthetic sealant includes cyanoacrylate based tissue sealant and others (polyethylene glycol and others). The market size and forecast for each type of products has been provided for the period 2012 to 2020, considering 2013 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2014 to 2020 for each segment.

Geographically, the global hemostasis and tissue sealing agents market has been segmented into four major regions namely North America, Europe, Asia Pacific and Rest of the World (RoW). The market size and forecast for each geography has been estimated for the period 2012 to 2020 in terms of revenue (USD million), considering 2013 as the base year. The report also provides the compounded annual growth rate (CAGR %) during the forecast period from 2014 to 2020 for all the geographies mentioned above.

The market overview section of the report discusses the market dynamics with respect to the market drivers, restraints and opportunities. This section also covers market attractiveness analysis and event impact analysis of the global hemostasis and tissue sealing agents market. Market share (%) of major players operating in the market has also been provided for the year 2013, followed by a list of recommendations for existing and new players to enter and enhance market share. The report concludes with company profiles of key players operating in various segments of the market. Each company profile includes business overview, financial overview, product portfolio, business strategies and recent developments of the respective company. Some of the prominent players in the global hemostasis and tissue sealing agents market that have been profiled in the report include Johnson & Johnson Services, Inc., CryoLife, Inc., Baxter, Cohesion Technologies, C.R. Bard, Inc., Advance Medical Solution Group plc, Integra LifeScience, Pfizer, Inc. and others.

The Global Hemostasis and Tissue Sealing Agents market is segmented as follows:

Global Hemostasis and Tissue Sealing Agents Market, by Types of Products

  • Topical Hemostats
    • Mechanical Hemostats
    • Collagen based Topical Hemostats
    • Oxidized Regenerated Cellulose (ORC) based Topical Hemostats
    • Gelatin based Topical Hemostats
    • Polysaccharide based Topical Hemostat
    • Active Hemostats (Thrombin-Based Topical Hemostats)
    • Flowable Hemostats (Combination Topical Hemostats)
  • Adhesive and Tissue Sealing Agents
    • Natural Tissue Sealant
    • Fibrin Sealant
    • Other Natural Sealant (Albumin and Collagen based Tissue Sealant)
    • Synthetic Tissue Sealant
    • Cynoacrylate-Based Tissue Adhesives
    • Other Synthetic Tissue Sealant (Polyethylene Glycol and others)
    • Adhesion Barrier Products

Global Hemostasis and Tissue Sealing Agents Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Table of Contents

Chapter 1 Preface

  • 1.1 Report Description
  • 1.2 Market Segmentation
  • 1.3 Research Methodology
    • 1.3.1 Sources
      • 1.3.1.1 Secondary Research
      • 1.3.1.2 Primary Research
      • 1.3.1.3 Assumption

Chapter 2 Executive Summary

  • 2.1 Market Snapshot: Global Hemostasis and Tissue Sealing Agents Market (2013 & 2020)
  • 2.2 Global Hemostasis and Tissue Sealing Agents Market, by Types of Products, 2013 (USD Million)
    • 2.2.1 Comparative Analysis: Global Hemostasis and Tissue Sealing Agents Market, by Geography, 2013 and 2020 (Value %)

Chapter 3 Market Overview

  • 3.1 Overview
  • 3.2 Market Dynamics
    • 3.2.1 Market Drivers
      • 3.2.1.1 Technology improvements coupled with new product development
      • 3.2.1.2 Rising trend of minimally invasive procedures
      • 3.2.1.3 Aging population increases the number of surgeries needing hemostat products
        • 3.2.1.3.1 Global Percentage Change in the World's Population by Age: 2010-2050
    • 3.2.2 Market Restraints
      • 3.2.2.1 High cost and strict regulatory requirement
      • 3.2.2.2 Risk of complications
    • 3.2.3 Opportunities
      • 3.2.3.1 Investing in emerging economies provides a good platform for companies to record high revenue
        • 3.2.3.1.1 Latin America Aging Population % Change as Compared to the total Latin American Population Age: 2005 - 2050
      • 3.2.3.2 Strong research and development
  • 3.3 Porter's Five Forces Analysis: Global Hemostasis and Tissue Sealing Agents Market
    • 3.3.1 Bargaining power of suppliers
    • 3.3.2 Bargaining power of buyers
    • 3.3.3 Threat of substitutes
    • 3.3.4 Threat of new entrants
    • 3.3.5 Competitive rivalry
  • 3.4 Market Attractiveness Analysis: Global Hemostasis and Tissue Sealing Agents Market, by Geography
  • 3.5 Market Share by Key Players of Global Hemostasis and Tissue Sealing Agents Market, 2013 (%)
    • 3.5.1 Global Hemostasis and Tissue Sealing Agents Market Share Analysis, by Key Players, 2013 (%)

Chapter 4 Global Hemostasis and Tissue Sealing Agents Market, by Types of Products

  • 4.1 Overview
    • 4.1.1 Global Hemostasis and Tissue Sealing Agents Market Revenue, by Types of Products, 2012 - 2020 (USD Million)
  • 4.2 Topical Hemostats
    • 4.2.1 Global Topical Hemostats Market Revenue, by Types, 2012 - 2020 (USD Million)
    • 4.2.2 Mechanical Hemostats
      • 4.2.2.1 Global Mechanical Hemostats Market Revenue, by Types, 2012 - 2020 (USD Million)
      • 4.2.2.2 Collagen-based Hemostats
        • 4.2.2.2.1 Global Collagen-based Hemostats Market Revenue, 2012 - 2020, (USD Million)
      • 4.2.2.3 Oxidized Regenerated Cellulose-based (ORC) Hemostats
        • 4.2.2.3.1 Global ORC-based Topical Hemostats Market Revenue, 2012 - 2020, (USD Million)
      • 4.2.2.4 Gelatin-based Hemostats
        • 4.2.2.4.1 Global Gelatin-based Hemostats Market Revenue, 2012 - 2020, (USD Million)
      • 4.2.2.5 Polysaccharide-based Hemostats
        • 4.2.2.5.1 Global Polysaccharide-based Hemostats Market Revenue, 2012 - 2020, (USD Million)
    • 4.2.3 Active Hemostats (Thrombin-based Topical Hemostats)
      • 4.2.3.1 Global Active Hemostats Market Revenue, 2012 - 2020, (USD Million)
    • 4.2.4 Flowable Hemostats (Combination Topical Hemostats)
      • 4.2.4.1 Global Flowable Hemostats Market Revenue, 2012 - 2020, (USD Million)
  • 4.3 Adhesive and Tissue Sealing Agents
    • 4.3.1 Global Adhesive and Tissue Sealing Agents Market Revenue, by Types, 2012 - 2020 (USD Million)
    • 4.3.2 Natural Tissue Sealant
      • 4.3.2.1 Global Natural Tissue Sealants Market Revenue, by Types, 2012 - 2020 (USD Million)
      • 4.3.2.2 Fibrin-based Tissue Sealant
        • 4.3.2.2.1 Global Fibrin-based Tissue Sealant Market Revenue, 2012 - 2020, (USD Million)
      • 4.3.2.3 Other Natural Tissue Sealant (Albumin and Collagen based tissue Sealant)
        • 4.3.2.3.1 Global Other Natural Tissue Sealant Market Revenue, 2012 - 2020, (USD Million)
    • 4.3.3 Synthetic Tissue Sealant
      • 4.3.3.1 Global Synthetic Tissue Sealant Market Revenue, by Types, 2012 - 2020 (USD Million)
      • 4.3.3.2 Cyanoacrylate-based Tissue Sealant
        • 4.3.3.2.1 Global Cyanoacrylate-based Tissue Sealant Market Revenue, 2012 - 2020, (USD Million)
      • 4.3.3.3 Other Synthetic Tissue Sealant (Polyethylene Glycol and others)
        • 4.3.3.3.1 Global Other Synthetic Tissue Sealant Market Revenue, 2012 - 2020, (USD Million)
    • 4.3.4 Adhesion Barrier Products
      • 4.3.4.1 Global Adhesion Barrier Products Market Revenue, 2012 - 2020, (USD Million)

Chapter 5 Global Hemostasis and Tissue Sealing Agents Market, by Geography

  • 5.1 Overview
    • 5.1.1 Global Hemostasis and Tissue Sealing Agents Market Revenue, by Geography, 2012 - 2020 (USD Million)
  • 5.2 North America
    • 5.2.1 North America Hemostasis and Tissue Sealing Agents Market Revenue, 2012 - 2020, (USD Million)
  • 5.3 Europe
    • 5.3.1 Europe Hemostasis and Tissue Sealing Agents Market Revenue, 2012 - 2020, (USD Million)
  • 5.4 Asia-Pacific
    • 5.4.1 Asia-Pacific Hemostasis and Tissue Sealing Agents Market Revenue, 2012 - 2020, (USD Million)
  • 5.5 Rest of the World (RoW)
    • 5.5.1 RoW Hemostasis and Tissue Sealing Agents Market Revenue, 2012 - 2020, (USD Million)

Chapter 6 Recommendations

  • 6.1 Market Strategy for Success
    • 6.1.1 Introduction of multi-usage and ready to use products
    • 6.1.2 Increasing emphasis on marketing campaigns
    • 6.1.3 Rigorous research and development initiatives

Chapter 7 Company Profiles

  • 7.1 Advanced Medical Solutions Group plc
    • 7.1.1 Company Overview
    • 7.1.2 Financial Overview
    • 7.1.3 Product Portfolio
    • 7.1.4 Business Strategies
    • 7.1.5 Recent Developments
  • 7.2 Baxter
    • 7.2.1 Company Overview
    • 7.2.2 Financial Overview
    • 7.2.3 Product Portfolio
    • 7.2.4 Business Strategies
    • 7.2.5 Recent Developments
  • 7.3 Cohera Medical, Inc.
    • 7.3.1 Company Overview
    • 7.3.2 Financial Overview
    • 7.3.3 Product Portfolio
    • 7.3.4 Business Strategies
    • 7.3.5 Recent Developments
  • 7.4 CryoLife, Inc.
    • 7.4.1 Company Overview
    • 7.4.2 Financial Overview
    • 7.4.3 Product Portfolio
    • 7.4.4 Business Strategies
    • 7.4.5 Recent Developments
  • 7.5 C.R. Bard, Inc.
    • 7.5.1 Company Overview
    • 7.5.2 Financial Overview
    • 7.5.3 Product Portfolio
    • 7.5.4 Business Strategies
    • 7.5.5 Recent Developments
  • 7.6 Johnson & Johnson Services, Inc.
    • 7.6.1 Company Overview
    • 7.6.2 Financial Overview
    • 7.6.3 Product Portfolio
    • 7.6.4 Business Strategies
    • 7.6.5 Recent Developments
  • 7.7 Integra LifeSciences Corporation
    • 7.7.1 Company Overview
    • 7.7.2 Financial Overview
    • 7.7.3 Product Portfolio
    • 7.7.4 Business Strategies
    • 7.7.5 Recent Development
  • 7.8 Pfizer, Inc.
    • 7.8.1 Company Overview
    • 7.8.2 Financial Overview
    • 7.8.3 Product Portfolio
    • 7.8.4 Business Strategies
    • 7.8.5 Recent Developments

List of Figures

  • FIG. 1 Global Hemostasis and Tissue Sealing Agents Market: Market Segmentation
  • FIG. 2 Global Hemostasis and Tissue Sealing Agents Market, by Types of Products, 2013 (USD Million)
  • FIG. 3 Comparative Analysis: Global Hemostasis and Tissue Sealing Agents Market, by Geography, 2013 and 2020 (Value %)
  • FIG. 4 Global Percentage Change in the World's Population by Age: 2010-2050
  • FIG. 5 Latin America Aging Population % Change Compared to the total Latin American Population Age: 2005 - 2050
  • FIG. 6 Porter's Five Forces Analysis: Global Hemostasis and Tissue Sealing Agents Market
  • FIG. 7 Market Attractiveness Analysis: Global Hemostasis and Tissue Sealing Agents Market, by Geography
  • FIG. 8 Global Hemostasis and Tissue Sealing Agents Market: Market Share, by Key Players, 2013 (%)
  • FIG. 9 Global Collagen-based Hemostats Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 10 Global ORC-based Topical Hemostats Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 11 Global Gelatin-based Hemostats Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 12 Global Polysaccharide-based Hemostats Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 13 Global Active Hemostats Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 14 Global Flowable Hemostats Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 15 Global Fibrin-based Tissue Sealant Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 16 Global Other Natural Tissue Sealant Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 17 Global Cyanoacrylate-based Tissue Sealant Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 18 Global Other Synthetic Tissue Sealant Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 19 Global Adhesion Barrier Products Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 20 North America Hemostasis and Tissue Sealing Agents Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 21 Europe Hemostasis and Tissue Sealing Agents Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 22 Asia-Pacific Hemostasis and Tissue Sealing Agents Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 23 RoW Hemostasis and Tissue Sealing Agents Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 24 Advanced Medical Solutions Group plc: Annual Revenues, 2011 - 2013 (USD Million)
  • FIG. 25 Baxter, Annual Revenue: 2011 - 2013 (USD Million)
  • FIG. 26 CryoLife, Inc.: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 27 C. R. Bard, Inc., Annual Revenue: 2011 - 2013 (USD Million)
  • FIG. 28 Johnson & Johnson Services, Inc., Annual Revenue: 2011 - 2013 (USD Million)
  • FIG. 29 Integra LifeSciences Corporation, Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 30 Pfizer, Inc., Annual Revenue, 2011 - 2013 (USD Million)

List of Tables

  • TABLE 1 Market Snapshot: Global Hemostasis and Tissue Sealing Agents Market (2013 & 2020)
  • TABLE 2 Impact Analysis of Market Drivers
  • TABLE 3 Impact Analysis of Market Restraints
  • TABLE 4 Global Hemostasis and Tissue Sealing Agents Market Revenue, by Types of Products, 2012 - 2020 (USD Million)
  • TABLE 5 Global Topical Hemostats Market Revenue, by Types, 2012 - 2020 (USD Million)
  • TABLE 6 Global Mechanical Hemostats Market Revenue, by Types, 2012 - 2020 (USD Million)
  • TABLE 7 Global Adhesive and Tissue Sealing Agents Market Revenue, by Types, 2012 - 2020 (USD Million)
  • TABLE 8 Global Natural Tissue Sealants Market Revenue, by Types, 2012 - 2020 (USD Million)
  • TABLE 9 Global Synthetic Tissue Sealant Market Revenue, by Types, 2012 - 2020 (USD Million)
  • TABLE 10 Global Hemostasis and Tissue Sealing Agents Market Revenue, by Geography, 2012 - 2020 (USD Million)
Back to Top